BEIJING, June 4 /PRNewswire-Asia-FirstCall/ — China
Medical Technologies, Inc. (the “Company”) (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic
(“IVD”) company, today announced its unaudited financial results
for the fourth fiscal quarter (“4Q FY2009”) and the full fiscal
year ended March 31, 2010
(“FY2009”).
4Q FY2009 Highlights
— Revenues decreased by 29.3% year-over-year to RMB175.7 million (US$25.7
million) but increased by 2.0% sequentially.
— Income from continuing operations and net income was RMB9.1 million
(US$1.3 million).
— Non-GAAP income from continuing operations, as defined below, decreased
by 57.2% year-over-year to RMB51.5 million (US$7.5 million) but
increased by 12.8% sequentially.
— Diluted earnings from continuing operations per ADS* was RMB0.35
(US$0.05).
— Non-GAAP diluted earnings from continuing operations per ADS*, as
defined below, decreased by 56.7% year-over-year to RMB1.98 (US$0.29)
but increased by 13.8% sequentially.
— Net cash generated from operations was RMB59.8 million (US$8.8 million).
— Approximately 110,000 ADSs* were repurchased under the Company’s share
repurchase program.
— Approximately RMB76.8 million (US$11.2 million) 4% convertible notes
were purchased and cancelled by the Company. Approximately 192,000
ADSs* were returned to the Company under the share lending agreement in
connection with the issuance of 4% convertible notes in August 2008.
FY2009 Highlights
— Revenues decreased by 12.9% year-over-year to RMB723.1 million
(US$105.9 million).
— Loss from continuing operations and net loss
‘/>”/>
